Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Feb 2019
- Ended
- 1 Jun 2024
- Type of study
- Observational, 3 groups
- Record updated
- 26 February 2019
- Why it stopped
- Withdrawing study from PRS-this is not an actual clinical trial
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (2)Hide the full registry criteria
Who can take part
- Ankle Brachial Index (ABI) ≥ 0.5 (bedside ABI is acceptable for screening purposes as the formal imaging ABI may not be resulted prior to surgery); One or more chronic lower extremity wounds that are located in the ankle area or below that has persisted a minimum of 30 days prior to the Screening visit, however, only one wound per subject will be included; Ulcer grade I or II, Stage A-D, according to University of Texas Wound Classification System; ≥21 years of age or older; Diagnosis of diabetes mellitus
Who cannot take part
- • Subject has major immunodeficiency; Subject is human immunodeficiency virus (HIV)+; Subject has untreated osteomyelitis; Subject has active cellulitis; Subject has active charcot; Is pregnant or plans to become pregnant; Is nursing or actively lactating; Developmental disability/significant psychological disorder that in the opinion of the investigator could impair the subject's ability to provide informed consent, participate in the study protocol or record study measures, including untreated schizophrenia, bipolar disorder and psychiatric hospitalization within the last 2 years; Active alcohol or substance abuse in the opinion of the investigator that could impair the subject's ability to provide informed consent, participate in the study protocol or record study materials
Where in United States
- UT Southwestern Medical Center at DallasDallas, United States
About the trial
What the trial wants to find out
The investigators plan to enroll up to 750 subjects over the course of 5 years. Study duration will be 2 visits over 7 days (+/-3). Participants will be consented and undergo baseline procedures. Participants will be grouped into 1 of 3 groups, based on infection and antibiotic status at screening. Debridement will be performed per standard of care and collection of tissue will be taken from this discarded tissue. A blood draw will be performed at each of these two visits as well. This is for research purposes only. All other data will be obtained from the electronic medical record. All standard of care except for the blood draws.
The 3 groups in the trial
- Cohort 1
Cohort 1: clinically uninfected (1A and 1C) ulcers.
- Cohort 2
Cohort 2: clinically infected (redness, edema, induration, heat, exudate, tenderness/pain (1B and 1D)) with no recent antibiotic therapy (within 28 days)
- Cohort 3
Cohort 3: clinically infected (redness, edema, induration, heat, exudate, tenderness/pain (1B and 1D)) on antibiotic therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 26 February 2019